GENE ONLINE|News &
Opinion
Blog

2021-10-21| Special

Reimagining the Healthcare System Innovation Ecosystem in Europe, Post-COVID

by Sahana Shankar
Share To
The COVID-19 pandemic transformed the pharma industry in the past two years, accelerating research and dialogue between stakeholders while unraveling significant deficiencies in the public healthcare infrastructure across the globe. At the tail-end of the pandemic, pioneers in healthcare took stock of the innovation, policies, and infrastructure at the Reuters event, Pharma 2021.

The first keynote panel discussion had industry experts look at the future of the healthcare innovation ecosystem in Europe. The panel comprised of 1. Nathalie Moll, Director General of EFPIA, European Federation of Pharmaceutical Industries and Associations 2. Jo De Cock, , Former Administrative General, INAMI, Institut national d'assurance maladie-invalidité, Belgium 3. Meindert Boysen, Director of National Institute of Health and Care Excellence, UK 4. Iskra Reic, Executive VP-AstraZeneca, Europe and Canada

Recounting their key learnings from the pandemic, the panelists shared optimism in incorporating collaboration and flexibility into building the future healthcare infrastructure.

GO Prime with only $1.49 now

LATEST
Topo-1 and FRα: Key Focus Areas and Major Collaborations in ADC Research – Part I
2024-07-23
Eli Lilly’s Tirzepatide Gets Approval in China for Weight Loss Management
2024-07-22
Roche Reports Positive Clinical Trial Results for Two Diabetes-Related Eye Disease Therapies
2024-07-19
7th Person in History Possibly Cured From HIV After Stem Cell Transplant for Acute Myeloid Leukemia
2024-07-19
Large RCT Finds Time-Lapse Imaging for Embryo Selection in IVF Does Not Improve Live Birth Rates
2024-07-19
Assessment of Supply Chain Risk Key to Improving Medicine Access
2024-07-18
SK Biopharma and Full-Life Sign US$571.5 Million Deal for Innovative Radiopharmaceutical FL-091
2024-07-18
EVENT
Scroll to Top